Department of Pulmonary, Allergy, and Critical Care Medicine, Geisinger Medical Center, Danville, USA.
Pulm Circ. 2011 Apr-Jun;1(2):138-59. doi: 10.4103/2045-8932.83444.
There have been tremendous strides in the management of pulmonary hypertension over the past 20 years with the introduction of targeted medical therapies and overall improvements in surgical treatment options and general supportive care. Furthermore, recent data shows that the survival of those with pulmonary arterial hypertension is improving. While there has been tremendous progress, much work remains to be done in improving the care of those with secondary forms of pulmonary hypertension, who constitute the majority of patients with this disorder, and in the optimal treatment approach in those with pulmonary arterial hypertension. This article will review general and targeted medical treatment, along with surgical interventions, of those with pulmonary hypertension.
在过去的 20 年中,随着靶向药物治疗的引入以及手术治疗选择和一般支持性护理的整体改善,肺动脉高压的治疗取得了巨大进展。此外,最近的数据表明,患有肺动脉高压的人的存活率正在提高。虽然已经取得了巨大的进展,但仍有许多工作要做,以改善继发性肺动脉高压患者的治疗,这些患者构成了大多数患有这种疾病的患者,以及在肺动脉高压患者中优化治疗方法。本文将回顾肺动脉高压患者的一般和靶向药物治疗以及手术干预。